2 afibrinogenemia-case report bijan keikhaei, ahvaz jundishapur university of medical sciences...

25
م ی ح ّ ر ل ا ن م ح ّ ر ل اّ ما س ب

Upload: amber-barrett

Post on 02-Jan-2016

215 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: 2 Afibrinogenemia-Case Report Bijan Keikhaei, Ahvaz Jundishapur University of Medical Sciences Medical Sciences

�ه الّر�حمن الّر�حیم بسم الّل

Page 2: 2 Afibrinogenemia-Case Report Bijan Keikhaei, Ahvaz Jundishapur University of Medical Sciences Medical Sciences

2

Afibrinogenemia-Case Report

Bijan Keikhaei, Ahvaz Jundishapur

University of Medical Sciences

Page 3: 2 Afibrinogenemia-Case Report Bijan Keikhaei, Ahvaz Jundishapur University of Medical Sciences Medical Sciences

3

Case Presentation•A 14 Yr-old boy, was referred to the Shafa Hospital on Mehr 1392, for the Acute loss of consciousness.

•He was a known case of hereditary afibrinogenemia who was diagnosed at age 4 th day from umbilical cord bleeding and serum fibrinogen level <0.2 g/l.

•Until 1392, only incidental minor bleeding episodes occurred.•He received a few fibrinogen concentrate vials in his life for mouth and gum bleeding.•History of trauma was not detected.•No positive family history.

Page 4: 2 Afibrinogenemia-Case Report Bijan Keikhaei, Ahvaz Jundishapur University of Medical Sciences Medical Sciences

Laboratory FindingsInvestigation findings were Hb-11gm/dl, MCV:

85Fl,MCH: 28 Pg, ESR-20mm,BUN:20 mg/dl, Cr:1 mg/dl

Platelet count-330000/cmm , PT- 17.5 sec (INR-

1.8), APTT- 72.8 sec,TT:Prolonged, HBSAg: Neg ,HIV

Ab: Neg, HCV Ab: Neg No measurable fibrinogen

Page 5: 2 Afibrinogenemia-Case Report Bijan Keikhaei, Ahvaz Jundishapur University of Medical Sciences Medical Sciences

5

Physical Examination

• Findings at neurological examination were as follows: • global motor weakness • GCS: 8• Babinski reflex on the right and left

Page 6: 2 Afibrinogenemia-Case Report Bijan Keikhaei, Ahvaz Jundishapur University of Medical Sciences Medical Sciences

6

Case report

• He was admitted in the ICU ward.• He had two episodes of generalized tonic

colonic convulsion in the ward .• Substitution therapy with fibrinogen were

started immediately after neurological examination .

• The patient received 100 mg/kg fibrinogen(Hemocomplettan P) every 48 hr.

• He also received phenytoin and Dexamethasone.

Page 7: 2 Afibrinogenemia-Case Report Bijan Keikhaei, Ahvaz Jundishapur University of Medical Sciences Medical Sciences

Brain CT Scan

Page 8: 2 Afibrinogenemia-Case Report Bijan Keikhaei, Ahvaz Jundishapur University of Medical Sciences Medical Sciences

Case Presentation

• While still on maintained substitution therapy, the patient condition becomes worse everyday.

• On day 3 th admission the patients GCS was 5.• The patient blood fibrinogen level was 3 g/l with

trough level 1.5 g/l.• Unfortunately the patient died on the 4 th day

admission.

Page 9: 2 Afibrinogenemia-Case Report Bijan Keikhaei, Ahvaz Jundishapur University of Medical Sciences Medical Sciences

Discussion

Page 10: 2 Afibrinogenemia-Case Report Bijan Keikhaei, Ahvaz Jundishapur University of Medical Sciences Medical Sciences

TermsDysfibrinogenemia: fibrinogen with abnormal function.

Hypofibrinogenemia: Reduced amount of fibrinogen in the plasma.

Hypodysfibrinogenemia: inherited fibrinogens which are both functionally abnormal and reduced amounts in the plasma (<150 mg/dL) as measured by immunologic methods.

Afibrinogenemia: absence of circulating fibrinogen in the plasma.

Cryofibrinogenemia: Fibrinogen in the plasma (but not serum) that precipitates on exposure to low temperatures (4 C).

Page 11: 2 Afibrinogenemia-Case Report Bijan Keikhaei, Ahvaz Jundishapur University of Medical Sciences Medical Sciences

Structure

340 kD glycoprotein that circulates in plasma at a concentration of ~ 200-400 mg/dL, with a half life of 4 days .

Hexamer, consisting of three paired polypeptide chains (Aα, Bβ, γ).

Synthesized in hepatocytes under the control of three different genes located on chromosome 4q.

Assembly takes place in the liver, carbohydrate side chains are added to the beta and gamma chains before it is secreted into plasma.

It has a trinodular structure: central E-domain (aminoterminal portions of the three polypeptides) and two D-domain (carboxyterminal portions)

Page 12: 2 Afibrinogenemia-Case Report Bijan Keikhaei, Ahvaz Jundishapur University of Medical Sciences Medical Sciences

Aα: Red Bβ: Blue γ: Green

E-domainD-Domain D-Domain

Page 13: 2 Afibrinogenemia-Case Report Bijan Keikhaei, Ahvaz Jundishapur University of Medical Sciences Medical Sciences

Two major forms exist, separated from each other by ion exchange chromatography: Fibrinogen 1 and 2.

Fibrinogen 1: contains 2 γ chain (411 aa)

Fibrinogen 2: contains one γ chain and one γ’ chain (427 aa), has a more anionic carboxyterminal sequence.

Factor XIII (protransglutaminase, fibrinoligase) binds specifically to γ’ chain of fibrinogen 2 (factor XIII is carried by fibrinogen 2 in the plasma). Thrombin has been shown to bind to the anionic γ’ extension of fibrin 2.

Structure

Page 14: 2 Afibrinogenemia-Case Report Bijan Keikhaei, Ahvaz Jundishapur University of Medical Sciences Medical Sciences

Sites of important function: Thrombin binding siteFactor XIIIa binding site, t-PA binding site, alpha-2 antiplasmin binding site platelet binding site.

Functions

Page 15: 2 Afibrinogenemia-Case Report Bijan Keikhaei, Ahvaz Jundishapur University of Medical Sciences Medical Sciences

ClassificationQuantitative Abnormalities

Congenital

Afibrinogenemia (uncommon, autosomal recessive)

HypofibrinogenemiaAcquired

Hypofibrinogenemia (consumptive coagulapathies, DIC)

Hyperfibrinogenemia (inflammation, neoplasia)

Qualitative abnormalities

Congenital

Dysfibrinogenemia

Hypodysfibrinogenemia

Acquired

Liver disease

Malignancies,

Antifibrinogen antibodies

Page 16: 2 Afibrinogenemia-Case Report Bijan Keikhaei, Ahvaz Jundishapur University of Medical Sciences Medical Sciences

Inherited dysfibrinogenemia

Overall, ~ 55 % are silent.

~ 25 % manifests as bleeding .

~ 20 % experience thrombosis with or without bleeding.

Page 17: 2 Afibrinogenemia-Case Report Bijan Keikhaei, Ahvaz Jundishapur University of Medical Sciences Medical Sciences

A rare condition,

Autosomal recessive inheritance complete lack of circulating fibrinogen• Bleeding manifestation range from mild to

catastrophic• Excessive bleeding and early miscarriages in

pregnant women• Fatal umbilical cord bleeding in the neonate

Inherited afibrinogenemia

Page 18: 2 Afibrinogenemia-Case Report Bijan Keikhaei, Ahvaz Jundishapur University of Medical Sciences Medical Sciences

• High fibrinogen levels are seen :– pregnancy –oral contraceptives. –hypercoagulable state. – acute-phase reactant.

Inherited afibrinogenemia

Page 19: 2 Afibrinogenemia-Case Report Bijan Keikhaei, Ahvaz Jundishapur University of Medical Sciences Medical Sciences

Diagnosis

Initial screening tests: thrombin time (TT) and reptilase time (RT) fibrinogen activity and antigen.

Afibrinogenemia: Prolonged TT, RT, virtually absent fibrinogen antigen and activity (clottable antigen).

Dysfibrinogenemia: Prolonged TT, RT, normal or increased fibrinogen antigen, normal or decreased clottable fibrinogen (activity).

Page 20: 2 Afibrinogenemia-Case Report Bijan Keikhaei, Ahvaz Jundishapur University of Medical Sciences Medical Sciences

Treatment

• In February 1995, cryoprecipitate was replaced by fibrinogen concentrate.

• Plasma recovery of fibrinogen has been measured repeatedly: top levels were approximately 1.7 g/L and trough levels approximately 0.75 g/L.

Page 21: 2 Afibrinogenemia-Case Report Bijan Keikhaei, Ahvaz Jundishapur University of Medical Sciences Medical Sciences

Patients with thrombotic complications should receive anticoagulation.

The optimal duration of anticoagulation is unknown (the benefit of anticoagulation should be weighed against a potentially higher risk of bleeding).

Patient education concerning thrombotic risk factors (surgery, pregnancy, oral contraceptives, immobilization)

Treatment

Page 22: 2 Afibrinogenemia-Case Report Bijan Keikhaei, Ahvaz Jundishapur University of Medical Sciences Medical Sciences

22

Discussion• Congenital afibrinogenemia is a rare disorder associated with a high risk of spontaneous intracerebral bleeding.

•Clinical manifestations in afibrinogenemia range from minor to severe bleeding, often with long asymptomatic intervals. Bleeding may occur spontaneously as well as related to trauma.

Page 23: 2 Afibrinogenemia-Case Report Bijan Keikhaei, Ahvaz Jundishapur University of Medical Sciences Medical Sciences

Discussion

• The incidence of spontaneous intracerebral bleeding in patients with afibrinogenemia is unknown; a small number of case reports have been published.

• spontaneous intracerebral bleeding must be strongly suspected when an afibrinogenemic patient presents with matching clinical symptoms.

Page 24: 2 Afibrinogenemia-Case Report Bijan Keikhaei, Ahvaz Jundishapur University of Medical Sciences Medical Sciences

Discussion

• Since intracerebral hemorrhage is a life-threatening event, It is recommend that substitution therapy be installed promptly at presentation, before additional investigations are made .

Page 25: 2 Afibrinogenemia-Case Report Bijan Keikhaei, Ahvaz Jundishapur University of Medical Sciences Medical Sciences